Overview

Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to investigate effect, tolerability and safety of different dosing regimens of AZD8848 administered intranasally to seasonal allergic rhinitis patients out of season in an allergen challenge model.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Adenosine